A Selective and Orally Bioavailable VHL-Recruiting PROTAC Achieves SMARCA2 Degradation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo
Nat Commun 2022 Oct 10;13(1)5969, C Kofink, N Trainor, B Mair, S Wöhrle, M Wurm, N Mischerikow, MJ Roy, G Bader, P Greb, G Garavel, E Diers, R McLennan, C Whitworth, V Vetma, K Rumpel, M Scharnweber, JE Fuchs, T Gerstberger, Y Cui, G Gremel, P Chetta, S Hopf, N Budano, J Rinnenthal, G Gmaschitz, M Mayer, M Koegl, A Ciulli, H Weinstabl, W FarnabyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.